Drawing for NOVOCARE

USPTO serial 79440839

NOVOCARE

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
CLYBURN, CARLA DIONNE
Law office
TMO LAW OFFICE 110

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVOCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly I. Boesche

Ashly I. Boesche PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD125 S Wacker DriveSuite 2050CHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical use.ACTIVE—
009Downloadable software in mobile applications for telehealth and telemedicine offerings for use by patients and healthcare professionals; downloadable software from websites for use by patients and healthcare professionals for the treatment of medical conditions; downloadable software for enabling patients to access general medical, health, and wellness information and advice; downloadable software for management and dispensing of medical prescriptions.ACTIVE—
016Instructional and teaching material.ACTIVE—
035Promoting public awareness about medical conditions; online business services in the nature of retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical preparations, location of healthcare professional, coordination of direct-to-consumer delivery of medicine.ACTIVE—
036Providing financial assistance to patients and healthcare providers for prescription pharmaceutical costs; providing information about patient reimbursement and insurance coverage for pharmaceuticals.ACTIVE—
041Educational services, namely, educational programmes, online electronic publication of reports, newsletters, and articles, online coaching and training services for patients and healthcare professionals related to the treatment of medical conditions.ACTIVE—
042Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products.ACTIVE—
044Providing information in the field of management of medical conditions; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to low-income patients without prescription drug coverage.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2026RFNTREFUSAL PROCESSED BY IB—
Apr 13, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 13, 2026RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2026DOCKASSIGNED TO EXAMINER—
Jan 15, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jan 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 2, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 1, 2026SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance